Kate E. Jarman

1.5k total citations
24 papers, 870 citations indexed

About

Kate E. Jarman is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Kate E. Jarman has authored 24 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Hematology. Recurrent topics in Kate E. Jarman's work include Malaria Research and Control (7 papers), Platelet Disorders and Treatments (5 papers) and Computational Drug Discovery Methods (3 papers). Kate E. Jarman is often cited by papers focused on Malaria Research and Control (7 papers), Platelet Disorders and Treatments (5 papers) and Computational Drug Discovery Methods (3 papers). Kate E. Jarman collaborates with scholars based in Australia, United States and Switzerland. Kate E. Jarman's co-authors include Stuart M. Pitson, Paul A.B. Moretti, Shaun P. Jackson, Simone M. Schoenwaelder, Julia R. Zebol, Akiko Ono, Emma C. Josefsson, Benjamin T. Kile, David C.S. Huang and M. J. D. White and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Kate E. Jarman

22 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate E. Jarman Australia	13	499	220	157	119	106	24	870
Magali Herrant France	10	637 1.3×	180 0.8×	200 1.3×	88 0.7×	179 1.7×	11	883
Baiteng Zhao United States	17	336 0.7×	157 0.7×	438 2.8×	83 0.7×	155 1.5×	30	985
Heriberto Bruzzoni‐Giovanelli France	15	570 1.1×	179 0.8×	281 1.8×	80 0.7×	145 1.4×	23	932
Nicholas Davies United Kingdom	15	584 1.2×	86 0.4×	298 1.9×	191 1.6×	86 0.8×	25	1000
Nader Omidvar United Kingdom	13	487 1.0×	190 0.9×	220 1.4×	71 0.6×	290 2.7×	18	946
Jehng-Kang Wang Taiwan	18	295 0.6×	142 0.6×	134 0.9×	136 1.1×	157 1.5×	40	854
Cong Peng China	20	655 1.3×	578 2.6×	215 1.4×	51 0.4×	157 1.5×	51	1.3k
Séverine Cathelin Canada	16	1.0k 2.1×	347 1.6×	186 1.2×	149 1.3×	285 2.7×	29	1.4k
Yoshiyasu Kaneko Japan	15	511 1.0×	144 0.7×	196 1.2×	82 0.7×	136 1.3×	55	966
Banibrata Sen United States	15	555 1.1×	59 0.3×	358 2.3×	96 0.8×	85 0.8×	21	923

Countries citing papers authored by Kate E. Jarman

Since Specialization

Citations

This map shows the geographic impact of Kate E. Jarman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate E. Jarman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate E. Jarman more than expected).

Fields of papers citing papers by Kate E. Jarman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate E. Jarman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate E. Jarman. The network helps show where Kate E. Jarman may publish in the future.

Co-authorship network of co-authors of Kate E. Jarman

This figure shows the co-authorship network connecting the top 25 collaborators of Kate E. Jarman. A scholar is included among the top collaborators of Kate E. Jarman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate E. Jarman. Kate E. Jarman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hodder, Anthony N., Brad E. Sleebs, G. W. Adams, et al.. (2025). Structure–activity analysis of imino‐pyrimidinone‐fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitors. FEBS Journal. 292(11). 2843–2864.

Mountford, Simon J., Maki Kiso, Danielle E. Anderson, et al.. (2025). Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus. Communications Medicine. 5(1). 140–140. 5 indexed citations

Richardson, Lachlan W., Trent D. Ashton, Madeline G. Dans, et al.. (2022). Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity. ChemMedChem. 17(18). e202200306–e202200306. 6 indexed citations

Ruiz, Manuel de Lera, Paola Favuzza, Zhuyan Guo, et al.. (2022). The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria. ACS Medicinal Chemistry Letters. 13(11). 1745–1754. 12 indexed citations

Nguyen, William, Erinna F. Lee, Marco Evangelista, et al.. (2021). Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2. ACS Infectious Diseases. 7(5). 1143–1163. 3 indexed citations

Sleebs, Brad E., Kate E. Jarman, Sonja Frölich, et al.. (2020). Development and application of a high-throughput screening assay for identification of small molecule inhibitors of the P. falciparum reticulocyte binding-like homologue 5 protein. International Journal for Parasitology Drugs and Drug Resistance. 14. 188–200. 3 indexed citations

Järvå, Michael, Marija Dramićanin, James P. Lingford, et al.. (2020). Structural basis of substrate recognition and catalysis by fucosyltransferase 8. Journal of Biological Chemistry. 295(19). 6677–6688. 26 indexed citations

Nguyen, William, Kate E. Jarman, T. Blackmore, et al.. (2020). Optimization of 5-substituted thiazolyl ureas and 6-substituted imidazopyridines as potential HIV-1 latency reversing agents. European Journal of Medicinal Chemistry. 195. 112254–112254. 5 indexed citations

Nguyen, William, Kate E. Jarman, Hélène Jousset Sabroux, et al.. (2019). Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models. Journal of Medicinal Chemistry. 62(10). 5148–5175. 14 indexed citations

10.

Chen, Augustine, et al.. (2019). A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells. Scientific Reports. 9(1). 12511–12511. 10 indexed citations

11.

Nguyen, William, Anthony N. Hodder, Peter E. Czabotar, et al.. (2018). Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P 2 position of PEXEL peptidomimetics. European Journal of Medicinal Chemistry. 154. 182–198. 23 indexed citations

12.

Zhu, Wenying, Kate E. Jarman, Noor A. Lokman, et al.. (2017). CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1. Cancer Research. 77(18). 4823–4834. 24 indexed citations

13.

Gilson, Paul R., Kate E. Jarman, Kym N. Lowes, et al.. (2017). Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity. Journal of Medicinal Chemistry. 60(3). 1171–1188. 48 indexed citations

14.

Au‐Yeung, George, Walid J. Azar, Thomas J. Mitchell, et al.. (2016). Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition. Clinical Cancer Research. 23(7). 1862–1874. 100 indexed citations

15.

Gazdik, Michelle, Kate E. Jarman, Matthew T. O’Neill, et al.. (2016). Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V. Bioorganic & Medicinal Chemistry. 24(9). 1993–2010. 10 indexed citations

16.

Zhu, Wenying, Briony L. Gliddon, Kate E. Jarman, et al.. (2016). CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1. Oncogene. 36(18). 2619–2627. 26 indexed citations

17.

Schoenwaelder, Simone M., Kate E. Jarman, Elizabeth E. Gardiner, et al.. (2011). Bcl-xL–inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 118(6). 1663–1674. 260 indexed citations

18.

Jarman, Kate E., Paul A.B. Moretti, Julia R. Zebol, & Stuart M. Pitson. (2009). Translocation of Sphingosine Kinase 1 to the Plasma Membrane Is Mediated by Calcium- and Integrin-binding Protein 1. Journal of Biological Chemistry. 285(1). 483–492. 122 indexed citations

19.

Schoenwaelder, Simone M., Akiko Ono, Warwick S. Nesbitt, et al.. (2009). Phosphoinositide 3-Kinase p110β Regulates Integrin αIIbβ3 Avidity and the Cellular Transmission of Contractile Forces. Journal of Biological Chemistry. 285(4). 2886–2896. 64 indexed citations

20.

Mazlan, Rafidah, Joseph Kei, Louise Hickson, et al.. (2009). Test–Retest Reliability of Acoustic Reflex Test in 6-Week-Old Healthy Infants. 31(1). 25–32.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact